Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: BAE Systems, Chemring

(Sharecast News) - ShoreCap termed BAE System's latest interims "a vote of confidence" and reiterated its 'buy' recommendation on the defence contractor's shares on the back of recent weakness. "These results are a vote of confidence for the Group and supports our view that BAE Systems deserves to retain its position as the premium option across our UK defence coverage," they said in a research note sent to clients.

In their opinion, the approximately 10% downdraft in the shares from their late April highs was triggered by the U.S. debt ceiling saga and the failed Wagner mutiny.

But both were now in the rear-view mirror, they said and the macroeconomic landscape remained "favourable" for the engineer.

Among other factors, they called attention to the group's better-than-expected free cash flow during the half of £1,07bn (ShoreCap: £311m).

They also anticipated that they would upgrade their fair value estimate of 1,166.0p on the shares.

Analysts at Berenberg bumped up their target price for shares of Chemring from 360.0p to 370.0p, pointing out the strength of its fundamentals and labelling the shares as their 'top pick' in the UK defence space.

The move followed the aerospace and defence technologies group's decision to unveil a share buyback programme.

In particular, the analysts noted that the company offered the highest margins on its earnings before interest and taxes and lowest leverage in UK defence for 2023.

And Chemring's Roke and Energetics businesses were likely to sustain its top-line growth.

Together, those two units accounted for more than half of group revenue.

They also raised their outer year earnings per share estimates by 5%.

All told, they judged the shares' valuation to be "attractive" in the wake of the 20% de-rating seen over the past year.

That had left the shares trading at 13.8 their estimates for Chemring's earnings in 2024.

Share this article

Related Sharecast Articles

Broker tips: Volution, Videndum
(Sharecast News) - Jefferies reiterated its 'buy' rating and 510.0p target price on Volution on Wednesday as it said the company's ability to drive margins higher, through both revenue mix and efficiency, is more than offsetting the challenging market backdrop to deliver ongoing earning upgrades.
Broker tips: Marlowe, Fevertree
(Sharecast News) - Analysts at Berenberg slightly lowered their target price on software and services firm Marlowe from 720.0p to 710.0p on Tuesday but said the group's divestment of certain Governance, Risk and Compliance software and service assets had left it with a "much cleaner and simpler-to-understand equity story".
Broker tips: JD Sports, NatWest
(Sharecast News) - Barclays downgraded JD Sports on Monday to 'equalweight' from 'overweight' and cut its price target for the stock to 140.0p from 165.0p after the retailer announced the acquisition of US rival Hibbett last week for $1.1bn.
Broker tips: NatWest, Pensionbee, Greggs
(Sharecast News) - Shore Capital reiterated its 'buy' rating on bank NatWest after a forecast-beating first quarter but said it sees the least amount of upside potential in the stock compared with the wider banking sector.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.